103 results
Page 3 of 6
8-K
EX-99.1
yue2jqkdsy66pr1x ce
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
EX-99.1
59cefq2
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
al6i hg2ys0l
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
8-K
EX-99.1
3qunjy6mw rqy1qm
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
oas2 v65kx
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
gdk9tld1c
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
1fs760rm59kc1f
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
831347w77 8ys7
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
EX-99.1
hjlw9aitzppy5ccf6u17
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
424B5
m2mvtbr
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
wb1c0i
22 Oct 19
Prospectus supplement for primary offering
4:24pm